Your browser doesn't support javascript.
loading
ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinib.
Dessilly, Géraldine; Elens, Laure; Panin, Nadtha; Karmani, Linda; Demoulin, Jean-Baptiste; Haufroid, Vincent.
Afiliação
  • Dessilly G; Louvain Centre for Toxicology & Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Elens L; Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Panin N; Louvain Centre for Toxicology & Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Karmani L; Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Demoulin JB; De Duve Institute, Université catholique de Louvain, Brussels, Belgium.
  • Haufroid V; Louvain Centre for Toxicology & Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
Pharmacogenomics ; 17(8): 883-90, 2016 06.
Article em En | MEDLINE | ID: mdl-27268766

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Polimorfismo de Nucleotídeo Único / Mesilato de Imatinib / Dasatinibe / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Polimorfismo de Nucleotídeo Único / Mesilato de Imatinib / Dasatinibe / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article